pharmaceuticals-and-healthcare

Global Irritable Bowel Syndrome (IBS) Therapeutics Market Insights, Forecast to 2025


Published On : Aug 2018

Category : Pharmaceutical

No. of Pages : 90 pages

  • $3900
  • $7800

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
This report studies the global market size of Irritable Bowel Syndrome (IBS) Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Irritable Bowel Syndrome (IBS) Therapeutics in these regions.
This research report categorizes the global Irritable Bowel Syndrome (IBS) Therapeutics market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

IBS is a chronic disorder characterized by abdominal pain or discomfort associated with altered bowel function for at least three months, according to the Rome III criteria. Patients often experience relapse of symptoms over time.
In 2017, the global Irritable Bowel Syndrome (IBS) Therapeutics market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Irritable Bowel Syndrome (IBS) Therapeutics market based on company, product type, application and key regions.

The various contributors involved in the value chain of Irritable Bowel Syndrome (IBS) Therapeutics include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Irritable Bowel Syndrome (IBS) Therapeutics include
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Valeant Pharmaceuticals International
Ardelyx
Astellas Pharma
Novartis
GlaxoSmithKline
Ironwood Pharmaceuticals

Market Size Split by Type
Blautix (Strain)
Bekinda (IBS-D)
SYN-010
Tenapanor
Market Size Split by Application
Hospital
Research

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Irritable Bowel Syndrome (IBS) Therapeutics market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Irritable Bowel Syndrome (IBS) Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Irritable Bowel Syndrome (IBS) Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Irritable Bowel Syndrome (IBS) Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Irritable Bowel Syndrome (IBS) Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Irritable Bowel Syndrome (IBS) Therapeutics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Irritable Bowel Syndrome (IBS) Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

In the recent times, the global market for Global irritable bowel syndrome ibs therapeutics market insights forecast to 2025 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Global irritable bowel syndrome ibs therapeutics market insights forecast to 2025 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Global irritable bowel syndrome ibs therapeutics market insights forecast to 2025 production processes, which is also reflecting positively on the growth of this market.

The research report on the Global irritable bowel syndrome ibs therapeutics market insights forecast to 2025 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Global irritable bowel syndrome ibs therapeutics market insights forecast to 2025 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Global irritable bowel syndrome ibs therapeutics market insights forecast to 2025, including the definition, classification, and industry chain structure of Global irritable bowel syndrome ibs therapeutics market insights forecast to 2025, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Global irritable bowel syndrome ibs therapeutics market insights forecast to 2025.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Global irritable bowel syndrome ibs therapeutics market insights forecast to 2025 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Global irritable bowel syndrome ibs therapeutics market insights forecast to 2025, implemented in each of the geographical segments. The predominant applications of the Global irritable bowel syndrome ibs therapeutics market insights forecast to 2025 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Global irritable bowel syndrome ibs therapeutics market insights forecast to 2025 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Global irritable bowel syndrome ibs therapeutics market insights forecast to 2025 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Picture of Irritable Bowel Syndrome (IBS) Therapeutics
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Production Market Share by Types (Product Category) in 2017
Figure Blautix (Strain) Product Picture
Table Major Manufacturers of Blautix (Strain)
Figure Bekinda (IBS-D) Product Picture
Table Major Manufacturers of Bekinda (IBS-D)
Figure SYN-010 Product Picture
Table Major Manufacturers of SYN-010
Figure Tenapanor Product Picture
Table Major Manufacturers of Tenapanor
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospital
Figure Research
Figure Irritable Bowel Syndrome (IBS) Therapeutics Report Years Considered
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size 2016-2025 (Million US$)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales 2016-2025 (K Units)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales by Regions 2016-2025 (K Units)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Regions 2016-2025
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Regions 2016-2025
Figure 2017 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Regions
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Regions 2016-2025 (Million US$)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Regions 2016-2025
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Regions 2016-2025
Figure 2017 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Regions
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales by Manufacturers (2016-2018) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Share by Manufacturers (2016-2018)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Share by Manufacturers in 2017
Table Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Manufacturers (2016-2018) (Million US$)
Table Irritable Bowel Syndrome (IBS) Therapeutics Revenue Share by Manufacturers (2016-2018)
Figure Irritable Bowel Syndrome (IBS) Therapeutics Value Share by Manufacturers in 2017
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Irritable Bowel Syndrome (IBS) Therapeutics Price (2016-2018) (USD/Unit)
Table Irritable Bowel Syndrome (IBS) Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Irritable Bowel Syndrome (IBS) Therapeutics Product Category
Table Date of International Manufacturers Enter into Irritable Bowel Syndrome (IBS) Therapeutics Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales by Type (2016-2025) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Share by Type (2016-2025)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Type (2016-2025)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Type in 2017
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Type (2016-2025) (Million US$)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Share by Type (2016-2025)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Type (2016-2025)
Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Type in 2017
Table Irritable Bowel Syndrome (IBS) Therapeutics Price by Type 2013-2018 (USD/Unit)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales by Application (2016-2025) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Share by Application (2016-2025)
Figure Global Sales Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Application (2016-2025)
Figure Global Sales Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Application (2016-2025)
Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate 2016-2025 (K Units)
Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries (2016-2025) (K Units)
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries (2016-2025)
Figure 2017 North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries (2016-2025) (Million US$)
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries
Figure United States Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure United States Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Canada Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales by Type (2016-2025) (K Units)
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Type (2016-2025)
Figure 2017 North America Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Type
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales by Application (2016-2025) (K Units)
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Application (2016-2025)
Figure 2017 North America Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Application
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales by Company (2016-2018) (K Units)
Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Company (2016-2018)
Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Company in 2017
Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate 2016-2025 (K Units)
Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries (2016-2025) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries (2016-2025) (Million US$)
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries
Figure Germany Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Germany Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (K Units)
Figure France Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure France Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (K Units)
Figure UK Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure UK Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Italy Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Russia Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales by Type (2016-2025) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Type (2016-2025)
Figure 2017 Europe Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Type
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales by Application (2016-2025) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Application (2016-2025)
Figure 2017 Europe Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Application
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales by Company (2016-2018) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Company (2016-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Company in 2017
Figure Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries
Figure China Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure China Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Japan Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Korea Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure India Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure India Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Australia Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales by Type (2016-2025) (K Units)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Type
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales by Application (2016-2025) (K Units)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Application
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales by Company (2016-2018) (K Units)
Table Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Company (2016-2018)
Figure Asia Pacific Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Company in 2017
Figure Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries (2016-2025) (K Units)
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries
Figure Brazil Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales by Type (2016-2025) (K Units)
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Type
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales by Application (2016-2025) (K Units)
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Application
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales by Company (2016-2018) (K Units)
Table Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Company (2016-2018)
Figure Central & South America Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Company in 2017
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Countries
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Countries
Figure GCC Countries Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Irritable Bowel Syndrome (IBS) Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Type
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Application
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Company in 2017
Table Abbott Laboratories Company Details
Table Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Abbott Laboratories Recent Development
Table Synergy Pharmaceuticals Company Details
Table Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Synergy Pharmaceuticals Recent Development
Table Sucampo Pharmaceuticals Company Details
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sucampo Pharmaceuticals Recent Development
Table Valeant Pharmaceuticals International Company Details
Table Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Valeant Pharmaceuticals International Recent Development
Table Ardelyx Company Details
Table Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Ardelyx Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Astellas Pharma Recent Development
Table Novartis Company Details
Table Novartis Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GlaxoSmithKline Recent Development
Table Ironwood Pharmaceuticals Company Details
Table Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Ironwood Pharmaceuticals Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Irritable Bowel Syndrome (IBS) Therapeutics Value Chain
Table Typical Suppliers of Key Irritable Bowel Syndrome (IBS) Therapeutics Raw Material
Table Irritable Bowel Syndrome (IBS) Therapeutics Customers List
Table Irritable Bowel Syndrome (IBS) Therapeutics Sales Channels
Table Irritable Bowel Syndrome (IBS) Therapeutics Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top